Dan Mendelson

    Morgan Health

    Dan Mendelson leads Morgan Health, an initiative investing off JPMorgan Chase's balance sheet into healthcare. In this conversation, we discuss how Morgan Health evaluates potential investments, why crossing over from Medicare Advantage into the commercial market is a major opportunity, and the reality of how rising healthcare costs impact employers.

    What did Dan Mendelson teach us?

    1. 01

      Mission fit comes before the financial story. Every investment must demonstrate measurable improvements in healthcare quality, affordability, or equity, or Morgan Health will pass regardless of the financial returns.

    2. 02

      Securing an investment from Morgan Health does not automatically grant access to JPMorgan Chase's covered lives. The bank manages its corporate benefits program independently from its investment fund.

    3. 03

      Morgan Health maintains a highly selective funnel, investing in roughly three out of 400 reviewed companies per year. Most checks target Series B and C startups that already have clean financials and mature leadership teams.

    4. 04

      Cost savings that come at the expense of patient care quality receive an immediate no. Successful solutions must curb employer spend while simultaneously protecting or improving the care experience.

    5. 05

      Medicare Advantage serves as a critical testing ground for value-based care models. Proven models from Medicare Advantage offer a clear blueprint to transition into the commercial employer market.

    6. 06

      AI delivers immediate impact through back-office administrative automation rather than direct patient interaction. At the same time, providers using AI for automated coding are actively driving up employer expenses.

    Lessons summarized from Sathvik Bilakanti's Substack write-up, not verbatim quotes.

    Episodes with Dan Mendelson